Chr. Hansen closes offering to retail investors in Denmark for amounts up to and including DKK 3 million.

Company announcement no.2/2010, May 31, 2010

NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH
AFRICA 

Due to strong demand for shares in Chr. Hansen Holding A/S (“Chr. Hansen”),
Chr. Hansen has resolved to close the offering to retail investors in Denmark
for amounts up to and including DKK 3 million. 

Information about the offer price and allocation is expected to be announced on
Thursday, June 3, 2010. 

For further information, please contact:                                        

Ole Andersen, Chairman                                                          
Tel: +45 4574 7109                                                              

Lars Frederiksen, CEO                                                           
Tel: +45 4574 7474                                                              

Ulrik Soendergaard, Corporate Communications                                 
Tel: +45 3038 2874                                                              


About Chr. Hansen                                                               
Chr. Hansen is a global bioscience company that develops natural ingredient     
solutions for the food, nutritional, pharmaceutical and agricultural industries.
All solutions are based on strong research and development competencies and     
significant technology investments. The company enjoys market leadership in all 
its divisions: Cultures & Enzymes, Health & Nutrition and Colors & Blends. There
are more than 2,200 dedicated employees in over 30 countries. For further       
information, please visit www.chr-hansen.com.                                   


DISCLAIMER                                                                      

The securities being offered have not been, and will not be, registered under   
the United States Securities Act of 1933, as amended (the "U.S. Securities Act")
or any U.S. state securities laws, and may not be offered or sold in the United 
States absent registration or any applicable exemption from the registration    
requirement of the U.S. Securities Act and applicable U.S. state securities     
laws.                                                                           

This release shall not constitute an offer to sell, or the solicitation of an   
offer to buy securities in the United States.  The information contained herein 
does not constitute an offer to sell or the solicitation of an offer to buy nor 
shall there be any sale of the securities referred to herein in the United      
States or any jurisdiction in which such offer, solicitation or sale would be   
unlawful prior to registration, exemption from registration or qualification    
under the securities laws of any jurisdiction.                                  

No public offer of securities is made outside of Denmark. Any offer of          
securities that may be deemed to be made pursuant to this communication in any  
EEA Member State that has implemented Directive 2003/71/EC (together with any   
applicable implementing measures in any Member State, the "Prospectus           
Directive") is only addressed to and is only directed at qualified investors in 
that Member State within the meaning of the Prospectus Directive.               

These materials are only being distributed to and are only directed at (i)      
persons who are outside the United Kingdom, subject to applicable laws or (ii)  
persons who have professional experience in matters relating to investments     
falling within the definition of "investment professionals" in Article 19(5) of 
the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005    
(the "Order"), and (iii) high net worth entities, and other persons to whom it  
may lawfully be communicated, falling within Article 49(2) of the Order (all    
such persons together being referred to as "relevant persons"). Any investment  
or investment activity to which these materials relate will only be available to
and will only be engaged with, relevant persons. Any person who is not a        
relevant person should not act or rely on this document or any of its contents. 

This announcement contains forward-looking statements pertaining to the timing  
of the offering, the offer price and allocation. These statements are based on  
current expectations that involve a number of risks and uncertainties which     
could cause actual results to differ from those anticipated.  A number of       
factors could cause actual results and developments to differ materially from   
those expressed or implied by the forward-looking statements. Save as required  
by law, Chr. Hansen does not undertake any obligation to update or revise any   
forward-looking statements, whether as a result of new information, future      
events or otherwise. You should not place undue reliance on forward-looking     
statements, which are applicable only as at the date they are made.